Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 1.5 million
Profit
Growing€ 574,631
▲ 366% vs 2024
Debts
Normal€ 9 million
▲ 5% vs 2024
ERC BELGIUM from Gembloux, company number BE0895963165, closed financial year 2025 with a result of € 574,631 after tax. For that financial year ERC BELGIUM recorded revenue of € 1.5 million and equity of € 2.5 million. Compared with financial year 2024, the result moved from € -215,987 to € 574,631. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
What happened at ERC BELGIUM?
What happened at ERC BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Vittorio LAURIENTE stepped down as director. NBB
- Joseph ELLIOT stepped down as director. NBB
- Bernard ALLIAUME stepped down as director. NBB
- Constantin JANSSEN DE LA BOESSIERE-THIENNES stepped down as director. NBB
- Mohamad KASSAS stepped down as director. NBB
- Apostolos STATHOPOULOS stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 574,631. Source: NBB ↗
- Agamemnon VARONOS stepped down as director. NBB
In short
From € 58,902 profit in 2021 to € 574,631 profit in 2025.
Paid € 2,114 in corporate taxes since 2021.
Best year ever: 2025, with € 574,631 profit.
On average € 1.8 million of value added per employee in 2025.
A new publication or filing at ERC BELGIUM? We notify you, reason included.
Follow ERC BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of ERC PHARMA, 80% of ERC THE NETHERLANDS and 80% of Erc USA itself.
Directors
According to the 2025 annual accounts
Vittorio LAURIENTE
Director
Also active at: SAMBRELEASE, FONDS DE CAPITAL A RISQUE 2020, LAURI INVEST +2 more
since 2024 · until 2029
Joseph ELLIOT
Vice-chairman of the board
since 2024 · until 2029
Metin BAKAR
Director
since 2025 · until 2026
Apostolos STATHOPOULOS
Managing director
since 2023 · until 2028
Agamemnon VARONOS
Director
since 2025 · until 2026
Bernard ALLIAUME
Vice-chairman of the board
since 2024 · until 2029
Constantin JANSSEN DE LA BOESSIERE-THIENNES
Director
Also active at: Mobilière et Immobilière du Centre, FEJ
since 2024 · until 2029
since 2024 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue Jean Sonet,Isnes 10
5032 Gembloux
Grotstraat 14
1020 Brussel
Active since 29 November 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
DIGITALOCEAN-ASN - DigitalOcean, LLC, US
DNS
GoDaddy DNS
Domain
Domain
erc-immunotherapy.com
Registered
2016-05-18
Registrar
GoDaddy.com, LLC
Expires
2026-05-18
Website info
Features
Security
Details
- Company number
- 0895.963.165
- VAT number
- BE 0895.963.165
- Registered office
- Rue Jean Sonet,Isnes 10, 5032 Gembloux
- Names & denominations
- ERC BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 25 February 2008
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- erc-immunotherapy.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van overige farmaceutische producten